As of 2024-12-13, the Fair Value of Theravance Biopharma Inc (TBPH) is -25.12 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.87 USD, the upside of Theravance Biopharma Inc is -354.48%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -236.50 | -278.00 | -199.40 | 872.10 | -55.19 | 20.60 |
| YoY growth | -9.74% | -17.55% | 28.27% | 537.36% | -106.33% | 86.40% |
| Market Cap (mil) | 485.31 |
| P/E | |
| Forward P/E |
| EPS | -1.00 |
| Avg earnings growth rate | 86.40% |
| TTM earnings | -49.40 |